{"id":"https://openalex.org/W4379983473","doi":"https://doi.org/10.1158/1538-7445.am2023-2118","title":"Abstract 2118: Development of RNAscope multiplex-based assay for exploratory pharmacodynamic biomarkers assessment in breast cancer patients from Phase I clinical trial of ORM-5029, a potent GSPT1 degrader","display_name":"Abstract 2118: Development of RNAscope multiplex-based assay for exploratory pharmacodynamic biomarkers assessment in breast cancer patients from Phase I clinical trial of ORM-5029, a potent GSPT1 degrader","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4379983473","doi":"https://doi.org/10.1158/1538-7445.am2023-2118"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-2118","doi":"https://doi.org/10.1158/1538-7445.am2023-2118","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2118","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114120846","display_name":"Shikha Saini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shikha Saini","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000294906","display_name":"Yeonjoon Kim","orcid":"https://orcid.org/0000-0002-4784-7925","observed_orcids":["https://orcid.org/0000-0002-4784-7925","https://orcid.org/0009-0002-0060-3592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yeonjoon Kim","raw_affiliation_strings":["2Orum Therapeutics, Daejon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Orum Therapeutics, Daejon, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wesley Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wesley Wong","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083409994","display_name":"Tina Karunaratne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina Karunaratne","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904704","display_name":"Olaf Christensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olaf Christensen","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108217263","display_name":"Sujoy Dutta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sujoy Dutta","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031562383","display_name":"Palash Bhar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Palash Bhar","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002257598","display_name":"Khuloud Takrouri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khuloud Takrouri","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038327301","display_name":"Nathan E. Fishkin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan Fishkin","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100865079","display_name":"Dong-Ki Choi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong-Ki Choi","raw_affiliation_strings":["2Orum Therapeutics, Daejon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Orum Therapeutics, Daejon, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103961132","display_name":"Minsoo Kim","orcid":"https://orcid.org/0000-0002-4621-5715","observed_orcids":["https://orcid.org/0000-0002-4621-5715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min-Soo Kim","raw_affiliation_strings":["2Orum Therapeutics, Daejon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Orum Therapeutics, Daejon, Republic of Korea","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084946395","display_name":"Joanne Mun-Yee Lim","orcid":"https://orcid.org/0000-0002-1326-8634","observed_orcids":["https://orcid.org/0000-0002-1326-8634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanne Lim","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018714903","display_name":"Anna Skaletskaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Skaletskaya","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029264475","display_name":"James J. Palacino","orcid":"https://orcid.org/0000-0003-4590-7290","observed_orcids":["https://orcid.org/0000-0003-4590-7290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Palacino","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011779065","display_name":"Peter Unnam Park","orcid":"https://orcid.org/0000-0002-6892-3018","observed_orcids":["https://orcid.org/0000-0002-6892-3018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Park","raw_affiliation_strings":["1Orum Therapeutics, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Orum Therapeutics, Cambridge, MA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"2118","last_page":"2118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gspt1","display_name":"GSPT1","score":0.7020000219345093},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.8809999823570251},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.8299999833106995},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8500000238418579},{"id":"https://openalex.org/keywords/atf3","display_name":"ATF3","score":0.8420000076293945},{"id":"https://openalex.org/keywords/ddit3","display_name":"DDIT3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/integrated-stress-response","display_name":"integrated stress response","score":0.968999981880188},{"id":"https://openalex.org/keywords/protein-degraders","display_name":"protein degraders","score":0.5320000052452087},{"id":"https://openalex.org/keywords/bt474-cells","display_name":"BT474 cells","score":0.7459999918937683},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.5659999847412109},{"id":"https://openalex.org/keywords/immunofluorescence","display_name":"immunofluorescence","score":0.878000020980835},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.6000137329101562},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5910419821739197},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5070450305938721},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5065332651138306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4797200560569763},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4466264843940735},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3500930070877075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3138303756713867},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.268462598323822},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.24277040362358093}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-2118","doi":"https://doi.org/10.1158/1538-7445.am2023-2118","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-2118","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282919809","https://openalex.org/W4379329200","https://openalex.org/W4409690347","https://openalex.org/W4381194841","https://openalex.org/W7148830541","https://openalex.org/W4413293995","https://openalex.org/W4406898779","https://openalex.org/W4415947548","https://openalex.org/W4398764274","https://openalex.org/W4414579422"],"abstract_inverted_index":{"Abstract":[0],"Breast":[1],"cancer":[2,8,201,315,364],"is":[3,72,120,282],"the":[4,18,36,79,90,152,179,252,381],"most":[5],"common":[6],"invasive":[7],"in":[9,87,128,140,170,173,176,192,230,312,362],"women":[10],"worldwide":[11],"and":[12,54,83,109,117,126,137,162,166,172,185,190,194,227,250,254,276,294,393],"remains":[13],"a":[14,51,73,234,306,373],"clinical":[15,369],"challenge.":[16],"Addressing":[17],"unmet":[19],"need":[20],"for":[21,124,273,357,384],"better":[22],"therapeutics,":[23],"we":[24,149,203,239],"used":[25,272,304],"our":[26,258],"Dual-Precision":[27],"Targeted":[28],"Protein":[29],"Degradation":[30],"(TPD\u00b2":[31],"TM)":[32],"approach":[33,214],"that":[34,151,266],"merges":[35],"power":[37],"of":[38,43,78,89,101,106,111,154,160,164,181,188,217,225,236,247,353,371,380],"protein":[39,58,74,107,219],"degraders":[40],"with":[41,76,142,157,220,243,257,318],"precision":[42],"ADC":[44],"technology":[45],"to":[46,63,69,98,308],"design":[47],"ORM-5029.":[48,319],"It":[49],"delivers":[50],"highly":[52],"potent":[53,374],"precise":[55],"catalytic":[56],"GSPT1":[57,71,161,183,218,248,261,375],"degrader":[59,249,376],"molecule":[60],"(SMol006)":[61],"selectively":[62],"HER2-expressing":[64,143],"tumor":[65,174,196,231],"cells":[66,242],"via":[67],"conjugation":[68],"pertuzumab.":[70],"associated":[75],"regulation":[77],"translational":[80],"termination":[81],"complex,":[82],"its":[84],"loss":[85],"results":[86],"activation":[88,110,163,187],"integrated":[91],"stress":[92,112],"response":[93,113,311],"(ISR)":[94],"which":[95],"ultimately":[96],"leads":[97],"apoptosis.":[99],"Activation":[100],"ISR":[102],"triggers":[103],"overall":[104],"reduction":[105],"synthesis":[108],"genes":[114],"(e.g.,":[115],"ATF3":[116,189,226],"DDIT3).":[118],"ORM-5029":[119,155],"currently":[121,283],"being":[122,284],"investigated":[123],"safety":[125],"tolerability":[127],"an":[129,206,244],"open":[130],"label,":[131],"multicenter,":[132],"phase":[133],"1,":[134],"dose":[135],"escalation":[136],"expansion":[138],"study":[139],"patients":[141,316,365],"advanced":[144],"breast":[145,200,314,363],"tumors":[146],"(NCT05511844).":[147],"Here,":[148],"evidence":[150],"efficacy":[153],"correlates":[156],"pharmacodynamic":[158,310,359],"degradation":[159,184],"ATP3":[165],"DDIT3":[167,191,228],"transcripts":[168],"both":[169,274],"vitro":[171],"xenografts":[175],"mice.":[177],"With":[178],"aim":[180],"evaluating":[182],"consequent":[186],"pre-":[193],"post-treatment":[195],"samples":[197],"from":[198,366],"HER2+":[199,313],"patients,":[202],"are":[204],"developing":[205],"RNAscope":[207,287,299,354],"multiplex":[208,288,300],"(Leica":[209],"System)":[210],"assay":[211,301,356],"panel.":[212],"This":[213],"combines":[215],"detection":[216,224],"20zz":[221],"ISH":[222],"probe-mediated":[223],"mRNA":[229],"sections.":[232],"As":[233],"part":[235],"method":[237,307],"development,":[238],"treated":[240,317],"BT474":[241,291],"efficacious":[245],"concentration":[246],"optimized":[251,280],"immunofluorescence":[253,275],"immunohistochemistry":[255,277],"protocol":[256,281],"in-house":[259],"generated":[260],"antibody":[262],"(MAb001).":[263],"Data":[264],"showed":[265],"GSPT1-":[267],"MAb001":[268],"could":[269,302],"be":[270,303],"successfully":[271],"assays.":[278],"The":[279],"developed":[285],"into":[286],"workflow":[289],"using":[290],"FFPE":[292],"sections":[293],"tissue":[295],"microarrays.":[296],"In":[297],"summary,":[298],"as":[305],"determine":[309],"Citation":[320],"Format:":[321],"Shikha":[322],"Saini,":[323],"Yeonjoon":[324],"Kim,":[325,343],"Wesley":[326],"Wong,":[327],"Tina":[328],"Karunaratne,":[329],"Olaf":[330],"Christensen,":[331],"Sujoy":[332],"Dutta,":[333],"Palash":[334],"Bhar,":[335],"Khuloud":[336],"Takrouri,":[337],"Nathan":[338],"Fishkin,":[339],"Dong-Ki":[340],"Choi,":[341],"Min-Soo":[342],"Joanne":[344],"Lim,":[345],"Anna":[346],"Skaletskaya,":[347],"James":[348],"Palacino,":[349],"Peter":[350],"Park.":[351],"Development":[352],"multiplex-based":[355],"exploratory":[358],"biomarkers":[360],"assessment":[361],"Phase":[367],"I":[368],"trial":[370],"ORM-5029,":[372],"[abstract].":[377],"In:":[378],"Proceedings":[379],"American":[382],"Association":[383],"Cancer":[385,404],"Research":[386],"Annual":[387],"Meeting":[388],"2023;":[389],"Part":[390],"1":[391],"(Regular":[392],"Invited":[394],"Abstracts);":[395],"2023":[396],"Apr":[397],"14-19;":[398],"Orlando,":[399],"FL.":[400],"Philadelphia":[401],"(PA):":[402],"AACR;":[403],"Res":[405],"2023;83(7_Suppl):Abstract":[406],"nr":[407],"2118.":[408]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-06-10T00:00:00"}